Navigation Links
Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year
Date:5/12/2008

Zicam(R) retail consumer sales increased 25% for the 12 weeks ended March

23, 2008

SCOTTSDALE, Ariz., May 12 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets products that provide consumers with "better ways to get better(R)," today announced its financial results for the fourth quarter and fiscal year ended March 31, 2008.

For the fourth quarter ended March 31, 2008, the Company reported net sales of $33.0 million, a 73% increase above net sales of $19.0 million in the quarter ended March 31, 2007. Net income increased to approximately $5.7 million, or $0.59 per diluted share, compared to net income of approximately $1.7 million, or $0.17 per diluted share, in the prior year's quarter.

For the fiscal year ended March 31, 2008, net sales increased approximately 3%, to $101.0 million, compared to net sales of $97.6 million for the twelve months ended March 31, 2007. Additionally, net income increased approximately 59%, to $10.4 million, or $1.04 per diluted share, compared to net income of approximately $6.5 million, or $0.66 per diluted share, in the twelve months ended March 31, 2007.

Carl Johnson, President and Chief Executive Officer, said, "We are pleased to announce fiscal 2008 net sales exceeded $100 million and our Zicam(R) brand's growth continued to outpace the cough and cold category as a whole. Fiscal 2008 was challenging due to an unusually slow start to the cold and flu season and tightening inventory management practices by certain of our large customers. The cold and flu season did eventually arrive and we realized strong brand momentum during the second half of the cold season. Zi
'/>"/>

SOURCE Matrixx Initiatives, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2008 Financial Results
2. Rising Medical Solutions Partners With myMatrixx to Deliver Integrated Pharmacy Management Solutions
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
4. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
5. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
6. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
7. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
8. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
9. New Medicare and Medicaid Data Released: Featuring Up-To-Date Enrollment Trends, State Initiatives, Regional Market Share and Prescription Drug Benefits
10. CryoCath Announces Fiscal 2008 Second Quarter Results
11. OmniSonics Medical Technologies Announces First Patient Enrolled in SONIC II REGISTRY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... is available in Spanish . ... than half of the population in our Community. Excess ... which affects liver function. Fat accumulates in the liver ... fibrosis and finally, cirrhosis. To date, the most reliable ... Imaging techniques such as abdominal ecography detect it but ...
(Date:9/17/2014)... West Orange, NJ. September 17, 2014. Kessler Foundation ... grants awarded by the International Progressive Multiple Sclerosis ... Neuropsychology, Neuroscience & Traumatic Brain Injury Research, is ... at the efficacy of cognitive rehabilitation in individuals ... of 22 research grants awarded by the Alliance ...
(Date:9/17/2014)... International Journal of Surgery ( IJS ) has announced ... content: after 24 months published journal issues become available for ... is to improve surgical knowledge and patient care and ... all will improve efforts to achieve this. , Professor ... has always been a great place for authors to publish ...
(Date:9/17/2014)... 2014 Elsevier, a world-leading provider of scientific, ... announced the publication of a position statement by ... the journal Maturitas on the topic ... the most prevalent cancer in women, with slightly ... Western countries. Mammography screening is a well-established method ...
(Date:9/17/2014)... (GSA) invites all journalists to attend its 67th ... conference in the field of aging from November ... register free of charge. , An estimated 4,000 professionals ... Walter E. Washington Convention Center and Marriott Marquis Washington, ... Cells to Societies" and the program schedule contains more ...
Breaking Medicine News(10 mins):Health News:Magnetic resonance helps to detect and quantify fat in liver 2Health News:Kessler Foundation receives first-round grant from International Progressive Multiple Sclerosis Alliance 2Health News:Join GSA in Washington, DC, for the Nation's Premier Aging Conference 2
... genetic disease that causes deafness and dumbness has hit a ... victims belong to Gujjar community. // ,Health and Medical ... that at least 72 cases of the disease have surfaced ... New born babies are also affected by the disease" ...
... the brain of mice were augmented, conditions similar to ... was reported by researchers from Stanford University Medical Centre ... in the treatment of this disease in humans. According ... a drug along with cannabis-like chemicals resulted in a ...
... genetic disease, genetics researchers have identified a novel biological ... development, potentially in cases of mental retardation and autism. ... two genes that contribute to Cornelia deLange syndrome (CdLS), ... in 10,000 children. The disease varies from milder to ...
... by x-ray crystallography. The bundle contains eight copies of ... like and unlike colors, respectively. ,Researchers ... found in natural proteins, discovering that they can form ... protein. Their findings could help scientists design drugs that ...
... According to one of the major findings of a ... less than children who sleep less, and they //are ... years later. The results of this new study were ... Child Development. ,Conducted by researchers at ...
... artemisinin-based combination therapies to prevent malaria //parasites from developing ... the National Agency for Food and Drug Administration and ... the parasite already has grown resistant to chloroquine and ... be difficult to find another malaria treatment. ...
Cached Medicine News:Health News:Gene Found for Rare Disorder May Reveal New Pathway in Mental Retardation 2Health News:Man-Made Proteins Could Be More Useful Than Real Ones 2Health News:Man-Made Proteins Could Be More Useful Than Real Ones 3Health News:Childhood Obesity Linked With Sleep 2
(Date:9/17/2014)... 17, 2014  Bayer HealthCare will present data on ... th Annual Meeting, which takes place September 18-20 ... which will be shared through poster presentations, showcase Bayer,s ... Data will be presented in a scientific forum. ... in hemophilia A patients, Bayer is maintaining its commitment ...
(Date:9/17/2014)... -- Millions of people suffer from neck and arm pain as ... the FDA approved the launch of a clinical trial for ... by Spinal Kinetics, which may offer relief to people with ... Hospital for Special Surgery (HSS), the number one orthopedic hospital ... New York City and in the Northeast participating ...
(Date:9/17/2014)... , Sept. 17, 2014  Lightbeam Health Solutions ... Care Organization (Physician Direct ACO) to deploy the ... in providing better care while reducing costs. ... Physician Direct Accountable Care Organization is the ... (OPNS). The OPNS mission is to be the ...
Breaking Medicine Technology:Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 2Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 4Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 3
... Results Further Validate Lipidomic-Based Therapeutics as an Emerging Area ... ... DIEGO, Sept. 4 Lpath, Inc. (OTC Bulletin,Board: LPTN), the ... in several murine models of human cancer,and AMD with Lpathomab(TM), ...
... HistoRx AQUA(R)-based assays to evaluate, clinical utility of protein ... ... -, NEW HAVEN, Conn., Sept. 4 HistoRx, Inc., ... the Radiation,Therapy Oncology Group (RTOG), a National Cancer Institute-funded clinical,cooperative ...
Cached Medicine Technology:Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 2Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 3HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 2HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 3
... CLIP 5 mm clip applier contains ... designed for introduction and use through ... sleeve, or larger with the use ... of the shaft is approximately 28 ...
Pilling-Weck, medium-large clip size, 10mm, rotatable take apart...
Insert only, Ethicon medium-large clip size...
Ethicon, medium-large clip size, 10mm, rotatable take apart...
Medicine Products: